Status:
COMPLETED
Usefulness of Gadovist-enhanced FLAIR Imaging
Lead Sponsor:
Ryoo, In Seon
Conditions:
Malignant Tumors
Brain Lymphoma
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Polyplastic glioblastoma and metastatic brain cancer are the most common malignant brain tumors in adults. The primary diagnostic test for tumors in the brain shows magnetic resonance imaging or simil...
Detailed Description
Polyplastic glioblastoma and metastatic brain tumors are the most common brain tumors in adults. Polyplastic glioblastoma is the most common tumor among malignant primary brain tumors, and metastatic ...
Eligibility Criteria
Inclusion
- All patients who undergo treatment, including surgery, after examining contrast-enhanced MR with an intra-brain mass that must exclude malignant tumors.
- Adults over 19 years of age at the time of examination
- Patients who agreed to this clinical study
Exclusion
- In the case of severe cognitive of dysfunction or neurological defects (mRS\>3)
- Pregnant or lactating patient
- Patients who are allergic to MRI contrast agents or cannot perform MRI for other reasons.
- Patients participating in other drug clinical trials as of the screening day (observation studies are possible)
Key Trial Info
Start Date :
February 2 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 25 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05293990
Start Date
February 2 2017
End Date
January 25 2021
Last Update
March 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Korea University Guro Hospital
Seoul, Gurogu, South Korea, 08308